256 related articles for article (PubMed ID: 17392448)
1. Rates of and reasons for failure of commercial human immunodeficiency virus type 1 viral load assays in Brazil.
Drexler JF; de Souza Luna LK; Pedroso C; Pedral-Sampaio DB; Queiroz AT; Brites C; Netto EM; Drosten C
J Clin Microbiol; 2007 Jun; 45(6):2061-3. PubMed ID: 17392448
[TBL] [Abstract][Full Text] [Related]
2. Clinical comparison of branched DNA and reverse transcriptase-PCR and nucleic acid sequence-based amplification assay for the quantitation of circulating recombinant form_BC HIV-1 RNA in plasma.
Pan P; Tao X; Zhang Q; Xing W; Sun X; Pei L; Jiang Y
AIDS; 2007 Dec; 21 Suppl 8():S27-32. PubMed ID: 18172387
[TBL] [Abstract][Full Text] [Related]
3. Multicenter comparison of Roche COBAS AMPLICOR MONITOR version 1.5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex version 3.0 for quantification of human immunodeficiency virus type 1 RNA in plasma.
Murphy DG; Côté L; Fauvel M; René P; Vincelette J
J Clin Microbiol; 2000 Nov; 38(11):4034-41. PubMed ID: 11060065
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive comparison of the VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 MONITOR 1.5 assays on 1,000 clinical specimens.
Galli R; Merrick L; Friesenhahn M; Ziermann R
J Clin Virol; 2005 Dec; 34(4):245-52. PubMed ID: 16286047
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of the Cobas Amplicor HIV-1 Monitor Ultrasensitive Test, the new Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test and the Versant HIV RNA 3.0 assays for quantitation of HIV-1 RNA in plasma samples.
Berger A; Scherzed L; Stürmer M; Preiser W; Doerr HW; Rabenau HF
J Clin Virol; 2005 May; 33(1):43-51. PubMed ID: 15797364
[TBL] [Abstract][Full Text] [Related]
6. Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT.
Swanson P; de Mendoza C; Joshi Y; Golden A; Hodinka RL; Soriano V; Devare SG; Hackett J
J Clin Microbiol; 2005 Aug; 43(8):3860-8. PubMed ID: 16081923
[TBL] [Abstract][Full Text] [Related]
7. Discordance between viral loads determined by Roche COBAS AMPLICOR human immunodeficiency virus type 1 monitor (version 1.5) Standard and ultrasensitive assays caused by freezing patient plasma in centrifuged becton-dickinson vacutainer brand plasma preparation tubes.
Salimnia H; Moore EC; Crane LR; Macarthur RD; Fairfax MR
J Clin Microbiol; 2005 Sep; 43(9):4635-9. PubMed ID: 16145119
[TBL] [Abstract][Full Text] [Related]
8. The first B/G intersubtype recombinant form of human immunodeficiency virus type 1 (HIV-1) identified in Germany was undetected or underquantitated by some commercial viral load assays.
von Truchsess I; Harris B; Schätzl HM; Hackett J
J Med Virol; 2006 Mar; 78(3):311-7. PubMed ID: 16419111
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of performance across the dynamic range of the Abbott RealTime HIV-1 assay as compared to VERSANT HIV-1 RNA 3.0 and AMPLICOR HIV-1 MONITOR v1.5 using serial dilutions of 39 group M and O viruses.
Swanson P; Huang S; Abravaya K; de Mendoza C; Soriano V; Devare SG; Hackett J
J Virol Methods; 2007 Apr; 141(1):49-57. PubMed ID: 17184853
[TBL] [Abstract][Full Text] [Related]
10. Quantitation of human immunodeficiency virus type 1 (HIV-1) RNA in cell-free cervicovaginal secretions: comparison of reverse transcription-PCR amplification (AMPLICOR HIV-A MONITOR 1.5) with enhanced-sensitivity branched-DNA assay (Quantiplex 3.0).
Si-Mohamed A; Andreoletti L; Colombet I; Carreno MP; Lopez G; Chatelier G; Kazatchkine MD; Belec L
J Clin Microbiol; 2001 Jun; 39(6):2055-9. PubMed ID: 11376034
[TBL] [Abstract][Full Text] [Related]
11. Initial evaluation of the Roche COBAS TaqMan HIV-1 v2.0 assay for determining viral load in HIV-infected individuals.
Taylor N; Schmid I; Egle A; Greil R; Patsch W; Oberkofler H
Antivir Ther; 2009; 14(8):1189-93. PubMed ID: 20032549
[TBL] [Abstract][Full Text] [Related]
12. Impact of HIV-1 genetic diversity on plasma HIV-1 RNA Quantification: usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based real-time reverse transcriptase polymerase chain reaction test.
Rouet F; Chaix ML; Nerrienet E; Ngo-Giang-Huong N; Plantier JC; Burgard M; Peeters M; Damond F; Ekouevi DK; Msellati P; Ferradini L; Rukobo S; Maréchal V; Schvachsa N; Wakrim L; Rafalimanana C; Rakotoambinina B; Viard JP; Seigneurin JM; Rouzioux C
J Acquir Immune Defic Syndr; 2007 Aug; 45(4):380-8. PubMed ID: 17468666
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the clinical sensitivity for the quantification of human immunodeficiency virus type 1 RNA in plasma: Comparison of the new COBAS TaqMan HIV-1 with three current HIV-RNA assays--LCx HIV RNA quantitative, VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 Monitor v1.5.
Katsoulidou A; Petrodaskalaki M; Sypsa V; Papachristou E; Anastassopoulou CG; Gargalianos P; Karafoulidou A; Lazanas M; Kordossis T; Andoniadou A; Hatzakis A
J Virol Methods; 2006 Feb; 131(2):168-74. PubMed ID: 16194575
[TBL] [Abstract][Full Text] [Related]
14. Comparative performance of three viral load assays on human immunodeficiency virus type 1 (HIV-1) isolates representing group M (subtypes A to G) and group O: LCx HIV RNA quantitative, AMPLICOR HIV-1 MONITOR version 1.5, and Quantiplex HIV-1 RNA version 3.0.
Swanson P; Soriano V; Devare SG; Hackett J
J Clin Microbiol; 2001 Mar; 39(3):862-70. PubMed ID: 11230396
[TBL] [Abstract][Full Text] [Related]
15. Molecular-based methods for quantifying HIV viral load.
Peter JB; Sevall JS
AIDS Patient Care STDS; 2004 Feb; 18(2):75-9. PubMed ID: 15006182
[TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of the VERSANT HIV-1 RNA 1.0 kinetic PCR molecular system (kPCR) for the quantification of HIV-1 plasma viral load.
Ruelle J; Jnaoui K; Lefèvre I; Lamarti N; Goubau P
J Clin Virol; 2009 Apr; 44(4):297-301. PubMed ID: 19230753
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of NucliSens HIV-1 QT and Amplicor HIV-1 monitor 1.5 in detecting HIV-1 viral load].
Pan PL; Xu WY; Yao J; Tao XX; Pei LJ; Jiang Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):177-9. PubMed ID: 17653329
[TBL] [Abstract][Full Text] [Related]
18. Multicenter evaluation of the NucliSens EasyQ HIV-1 v1.1 assay for the quantitative detection of HIV-1 RNA in plasma.
de Mendoza C; Koppelman M; Montès B; Ferre V; Soriano V; Cuypers H; Segondy M; Oosterlaken T
J Virol Methods; 2005 Jul; 127(1):54-9. PubMed ID: 15893566
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of three different commercial procedures for quantifying human immunodeficiency virus type-1 RNA levels.
Aschbacher R; Monari P; Lolli S; Donzelli C; Colangeli V; Vignoli M; Ramazzotti E; Furlini G; Re MC
New Microbiol; 1999 Jan; 22(1):1-9. PubMed ID: 10190111
[TBL] [Abstract][Full Text] [Related]
20. Measurement of HIV RNA in patients infected by subtype C by assays optimized for subtype B results in an underestimation of the viral load.
Gottesman BS; Grosman Z; Lorber M; Levi I; Shitrit P; Mileguir F; Gottesman G; Chowers MY
J Med Virol; 2004 Jun; 73(2):167-71. PubMed ID: 15122788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
